Substantial impact of 68Ga-PSMA-PET/CT on the radiotherapeutic approach for prostate cancer

被引：0
作者：
Schmidt-Hegemann, N. [1 ]
Eze, C. [1 ]
Li, M. [1 ]
Rogowski, P. [1 ]
Schaefer, C. [1 ]
Stief, C. [2 ]
Ganswindt, U. [3 ]
Bartenstein, P. [4 ]
Belka, C. [1 ]
Ilhan, H. [4 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiat Oncol, Munich, Germany
[2] Univ Hosp Munich, Dept Urol, Klin & Poliklin Urol, Munich, Germany
[3] Med Univ Innsbruck, Dept Therapeut Radiol & Oncol, Innsbruck, Austria
[4] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 133卷
关键词：
D O I：
10.1016/S0167-8140(19)31935-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1515
引用
收藏
页码：S820 / S820
页数：1
相关论文
共 50 条
  • [21] Comparison between 68Ga-PSMA-PET/CT and mpMRI for radiotherapy planning in primary prostate cancer
    Spohn, S.
    Jaegle, C.
    Bettermann, A. S.
    Kiefer, S.
    Jilg, C. A.
    Kranz-Rudolph, J.
    Fassbender, T. F.
    Bronsert, P.
    Nicolay, N. H.
    Bock, M.
    Ruf, J.
    Benndorf, M.
    Grosu, A. L.
    Zamboglou, C.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S104 - S104
  • [22] Contribution of 68GA-PSMA-PET/CT to Risk Classification In Prostate Cancer With Gleason Score 6
    Sahin, O.
    Beyhan, E.
    Fenercioglu, O. E.
    Arslan, E.
    Cermik, T. F.
    Ergul, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S522 - S522
  • [23] 68Ga-PSMA PET/CT in prostate cancer
    Garcia Garzon, J. R.
    de Arcocha Torres, M.
    Delgado-Bolton, R.
    Ceci, F.
    Alvarez Ruiz, S.
    Orcajo Rincon, J.
    Caresia Aroztegui, A. P.
    Garcia Velloso, M. J.
    Garcia Vicente, A. M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2018, 37 (02): : 130 - 138
  • [24] Prediction of the Gleason Score of Prostate Cancer Patients Using 68Ga-PSMA-PET/CT Radiomic Models
    Vosoughi, Zahra
    Emami, Farshad
    Vosoughi, Habibeh
    Hajianfar, Ghasem
    Hamzian, Nima
    Geramifar, Parham
    Zaidi, Habib
    JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING, 2024, 44 (05) : 711 - 721
  • [25] 68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT
    Bluemel, Christina
    Krebs, Markus
    Polat, Buelent
    Linke, Fraenze
    Eiber, Matthias
    Samnick, Samuel
    Lapa, Constantin
    Lassmann, Michael
    Riedmiller, Hubertus
    Czernin, Johannes
    Rubello, Domenico
    Bley, Thorsten
    Kropf, Saskia
    Wester, Hans-Juergen
    Buck, Andreas K.
    Herrmann, Ken
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (07) : 515 - 521
  • [26] 68Ga-PSMA-PET/CT and bone scintigraphy imaging for staging of high-risk prostate cancer
    Lengana, Thabo
    Modiselle, Moshe
    Lawal, Ismaheel
    Boshomane, Gill
    Ebenhan, Thomas
    Vorster, Mariza
    Sathekge, Machaba
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [27] Ga-68-PSMA PET/CT for Prostate Cancer
    Hellwig, D.
    Moosbauer, J.
    Eilles, C.
    AKTUELLE UROLOGIE, 2014, 45 (06) : 457 - 463
  • [28] The Impact of 68Ga-PSMA PET/CT and PET/MRI on the Management of Prostate Cancer
    Hoffmann, Manuela A.
    Wieler, Helmut J.
    Baues, Christian
    Kuntz, Nicholas J.
    Richardsen, Ines
    Schreckenberger, Mathias
    UROLOGY, 2019, 130 : 1 - 12
  • [29] Influence of urinary bladder activity on the detectability of local prostate cancer recurrence in 68Ga-PSMA-PET/CT
    Alberts, I. L.
    Sachpedikis, C.
    Dijkstra, L.
    Gourni, E.
    Meier, L.
    Cascato, R.
    Boxler, S.
    Gross, T.
    Thalmann, G.
    Rominger, A.
    Afshar, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S598 - S599
  • [30] Role of 68Ga-PSMA-PET/CT for the detection of primary prostate cancer prior to biopsy: a prospective study
    Jain, Harsh
    Sood, Rajeev
    Faridi, Mohammad Shazib
    Goel, Hemant
    Sharma, Umesh
    CENTRAL EUROPEAN JOURNAL OF UROLOGY, 2021, 74 (03) : 315 - 320
12345